Originally Published as The Niche PodcastGenentech’s next tech, GSK divests to invest, Bristol Myers Squibb checks oncology, Cassava Sciences raises capital, Libtayo gets expanded FDA approval, and Hyperfine turns on hyperdrive.

Sponsorshttps://www.thescopemethod.com

Story Referenceshttps://tinyurl.com/Niche-34-1
https://tinyurl.com/Niche-34-2
https://tinyurl.com/Niche-34-3
https://tinyurl.com/Niche-34-4
https://tinyurl.com/Niche-34-5
https://tinyurl.com/Niche-34-6

Music by Luke Goodsonhttps://www.soundcloud.com/lukegoodson

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.